ERFE and metabolic disease: The molecular mechanism of increasing levels of CTRP15 in patients with PCOS is not clear; however, changes in the regulation of CTRP15 in response to metabolic disorders such as insulin resistance in PCOS individuals could be suggested as a possible mechanism.